Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
by Schöffski, Patrick (Author)
, Tan, Daniel S.-W. (Author)
, Martín, Miguel (Author)
, Ochoa-de-Olza, María (Author)
, Sarantopoulos, John (Author)
, Carvajal, Richard D. (Author)
, Kyi, Chrisann (Author)
, Esaki, Taito (Author)
, Prawira, Amy (Author)
, Akerley, Wallace (Author)
, Braud, Filippo De (Author)
, Hui, Rina (Author)
, Zhang, Tian (Author)
, Soo, Ross A. (Author)
, Maur, Michela (Author)
, Weickhardt, Andrew (Author)
, Krauß, Jürgen (Author)
, Deschler-Baier, Barbara (Author)
, Lau, Allen (Author)
, Samant, Tanay S. (Author)
, Longmire, Tyler (Author)
, Chowdhury, Niladri Roy (Author)
, Sabatos-Peyton, Catherine A. (Author)
, Patel, Nidhi (Author)
, Ramesh, Radha (Author)
, Hu, Tiancen (Author)
, Carion, Ana (Author)
, Gusenleitner, Daniel (Author)
, Yerramilli-Rao, Padmaja (Author)
, Askoxylakis, Vasileios (Author)
, Kwak, Eunice L. (Author)
, Hong, David S. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource